Ismaili Ameije, Anthony Stefan, Clark Jessica
College of Osteopathic Medicine, Lake Erie College of Osteopathic Medicine, Bradenton, USA.
Dermatology, Coastal Skin Surgery and Dermatology, Panama City, USA.
Cureus. 2023 Apr 24;15(4):e38040. doi: 10.7759/cureus.38040. eCollection 2023 Apr.
Coronavirus disease 2019 (COVID-19) represents a multisystem disease that has caused a devastating global pandemic. The COVID-19 vaccine produced in response to the pandemic has been effective but can have side effects. One well-established condition is the reactivation of herpes zoster (HZ). Various risk factors increase the risk of HZ reactivation such as age, infections, and immunosuppressed states. HZ can have severe complications, including herpes zoster ophthalmicus and postherpetic neuralgia. Here, we present a unique case where a patient experienced HZ reactivation after both primary doses of the COVID-19 vaccine despite receiving early antiviral treatment.
2019年冠状病毒病(COVID-19)是一种多系统疾病,已引发了一场毁灭性的全球大流行。针对该大流行研发的COVID-19疫苗已证明有效,但可能会有副作用。一个已被充分证实的情况是带状疱疹(HZ)的再激活。多种风险因素会增加HZ再激活的风险,如年龄、感染和免疫抑制状态。HZ可能会引发严重并发症,包括眼部带状疱疹和带状疱疹后神经痛。在此,我们呈现一个独特病例,该患者在接种两剂COVID-19疫苗后出现了HZ再激活,尽管接受了早期抗病毒治疗。